Lexpos News

/Lexpos News

NMS myth busting series (#3)

View the first article on NMS myth busting View the second article on NMS myth busting The post NMS myth busting series (#3) appeared first on Community Pharmacy England.

By |May 18th, 2026|Lexpos News|Comments Off on NMS myth busting series (#3)

May 2026 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (15/05/2026) confirmed the following initial list of price concessions for May 2026: Drug Pack size Price concession Aspirin 75mg dispersible tablets 28 £2.83 Aspirin 75mg dispersible tablets 100 £10.10 Aspirin 75mg gastro-resistant tablets 28 £2.15 Benzydamine 0.15% oromucosal spray sugar free 30 £1.60 Captopril 25mg tablets [...]

The post May 2026 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |May 15th, 2026|Lexpos News|Comments Off on May 2026 Price Concessions 1st Update

NMS myth busting series (#2)

View the first article on NMS myth busting The post NMS myth busting series (#2) appeared first on Community Pharmacy England.

By |May 14th, 2026|Lexpos News|Comments Off on NMS myth busting series (#2)

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) DMRC reference number: DMRC- 39439934 Date issued: 14 May 2026 Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label. Marketing Authorisation Holder: Fresenius Medical Care Deutschland GmbH [...]

The post MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH) appeared first on Community Pharmacy England.

By |May 14th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis (Fresenius Medical Care Deutschland GmbH)

NMS myth busting series (#1)

    The post NMS myth busting series (#1) appeared first on Community Pharmacy England.

By |May 12th, 2026|Lexpos News|Comments Off on NMS myth busting series (#1)